Exact Mass: 502.47495519999995

Exact Mass Matches: 502.47495519999995

Found 20 metabolites which its exact mass value is equals to given mass value 502.47495519999995, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Plerixafor

1,1-(1,4-Phenylenebis-(methylene))-bis-1,4,8,11-tetraazacyclotetradecane octahydrochloride dihydrate

C28H54N8 (502.44712039999996)


Plerixafor is a hematopoietic stem cell mobilizer. It is used to stimulate the release of stem cells from the bone marrow into the blood in patients with non-Hodgkin lymphoma and multiple myeloma. These stem cells are then collected and used in autologous stem cell transplantation to replace blood-forming cells that were destroyed by chemotherapy. Plerixafor has orphan drug status in the United States and European Union; it was approved by the U.S. Food and Drug Administration on December 15, 2008. L - Antineoplastic and immunomodulating agents > L03 - Immunostimulants > L03A - Immunostimulants D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C308 - Immunotherapeutic Agent > C63817 - Chemokine Receptor Antagonist Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

2-(4-hydroxyphenyl)ethyl pentacosanoate

2-(4-hydroxyphenyl)ethyl pentacosanoate

C33H58O3 (502.4385718)


   

4-(24-hydroxy-1-oxo-5-n-propyltetracosanyl)phenol

4-(24-hydroxy-1-oxo-5-n-propyltetracosanyl)phenol

C33H58O3 (502.4385718)


   
   

(Z,Z)-8,26-Pentatriacontadien-2-one

(Z,Z)-8,26-Pentatriacontadien-2-one

C35H66O (502.5113386)


   

octahydroheptaprenol

octahydroheptaprenol

C35H66O (502.5113386)


   

(1R,6R,9S)-6-hydroxycaryophyllenyl (S)-6-hydroxystearate

(1R,6R,9S)-6-hydroxycaryophyllenyl (S)-6-hydroxystearate

C33H58O3 (502.4385718)


   

Plerixafor

1,4-bis((1,4,8,11-tetraazacyclotetradecan-1-yl)methyl)benzene, octahydrochloride

C28H54N8 (502.44712039999996)


L - Antineoplastic and immunomodulating agents > L03 - Immunostimulants > L03A - Immunostimulants D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C308 - Immunotherapeutic Agent > C63817 - Chemokine Receptor Antagonist Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

Linolenyl palmitate

9Z,12Z,15Z-octadecatrienyl hexadecanoate

C34H62O2 (502.47495519999995)


   

Linoleyl palmitatoleate

9Z,12Z-octadecadienyl 9Z-hexadecenoate

C34H62O2 (502.47495519999995)


   

Palmitoleyl linoleate

9Z-hexadecenyl 9Z,12Z-octadecadienoate

C34H62O2 (502.47495519999995)


   

Palmityl linolenate

hexadecanyl 9Z,12Z,15Z-octadecatrienoate

C34H62O2 (502.47495519999995)


   

FA 34:3

32-methyl-17Z,25Z-tritriacontadien-33-olide

C34H62O2 (502.47495519999995)


   

WE 34:3

hexadecanyl 9Z,12Z,15Z-octadecatrienoate

C34H62O2 (502.47495519999995)


   

tris(8-methylnonyl) phosphite

tris(8-methylnonyl) phosphite

C30H63O3P (502.4514578)


   
   
   

(20Z,23Z,26Z)-tetratriaconta-20,23,26-trienoic acid

(20Z,23Z,26Z)-tetratriaconta-20,23,26-trienoic acid

C34H62O2 (502.47495519999995)


   

Hydroxytritriacontatetraenoic acid

Hydroxytritriacontatetraenoic acid

C33H58O3 (502.4385718)